Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels

被引:12
作者
Garton, AM
Rennie, RP
Gilpin, J
Marrelli, M
Shafran, SD
机构
[1] Univ Alberta Hosp, Walter C Mackenzie Hlth Sci Ctr 2E4 11, Div Infect Dis, Dept Med, Edmonton, AB T6G 2M7, Canada
[2] Univ Alberta Hosp, Dept Pharm, Edmonton, AB T6G 2M7, Canada
[3] Univ Alberta Hosp, Dept Microbiol & Publ Hlth, Edmonton, AB T6G 2M7, Canada
关键词
D O I
10.1093/jac/40.6.903
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Serum cefuroxime concentrations were measured over a 12 h period in ten healthy adults following three iv dosing regimens: 750 mg cefuroxime, 1.5 g cefuroxime, and 750 mg cefuroxime with 1 g of probenecid given orally 3 h before the cefuroxime infusion. Probenecid prolonged the serum cefuroxime half-life by 63% (P < 0.05) with a significant increase in the mean time for which serum cefuroxime concentrations exceeded the MIC90 for common respiratory pathogens (2 mg/L) compared with either 750 mg cefuroxime (2.2 h, P < 0.05) or 1.5 g of cefuroxime (0.9 h, P < 0.05) without probenecid. The cost of the 750 mg cefuroxime dose plus probenecid is approximately half that of a 1.5 g cefuroxime dose.
引用
收藏
页码:903 / 906
页数:4
相关论文
共 7 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   CEFUROXIME - REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1979, 17 (04) :233-266
[3]  
CRAIG W, 1993, EUR J CLIN MICROBIOL, V12, P6
[4]  
FINCH R, 1993, BRIT J HOSP MED, V49, P346
[5]   CEFUROXIME - HUMAN PHARMACOKINETICS [J].
FOORD, RD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (05) :741-747
[6]   PHARMACOKINETICS OF CEFUROXIME AFTER INTRAVENOUS-INJECTION [J].
GOWER, PE ;
DASH, CH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (03) :221-227
[7]   GUIDELINES FOR THE INITIAL MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA - DIAGNOSIS, ASSESSMENT OF SEVERITY, AND INITIAL ANTIMICROBIAL THERAPY [J].
NIEDERMAN, MS ;
BASS, JB ;
CAMPBELL, GD ;
FEIN, AM ;
GROSSMAN, RF ;
MANDELL, LA ;
MARRIE, TJ ;
SAROSI, GA ;
TORRES, A ;
YU, VL .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (05) :1418-1426